Barratt Jonathan,Dellanna Frank,Portoles Jose,Choukroun Gabriel,De Nicola Luca,Young James,Dimkovic Nada B,Reusch Michael (2023) Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies, ADVANCES IN THERAPY, vol. 40, br. 4, str. 1546-1559 (Article) 

Barratt Jonathan,Dellanna Frank,Portoles Jose,Choukroun Gabriel,De Nicola Luca,Young James,Dimkovic Nada B,Reusch Michael (2023) Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies, ADVANCES IN THERAPY, vol. 40, br. 4, str. 1546-1559 (Article) 

Barratt Jonathan,Andric Branislav R,Tataradze Avtandil,Schoemig Michael,Reusch Michael,Valluri Udaya,Mariat Christophe (2021) Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES), NEPHROLOGY DIALYSIS TRANSPLANTATION, vol. 36, br. 9, str. 1616-1628 (Article)